EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Income Disparities in Survival and Receipt of Neoadjuvant Chemotherapy and Pelvic Lymph Node Dissection for Muscle-Invasive Bladder Cancer

Ryan M Antar iD, Vincent E Xu iD, Oluwafolajimi Adesanya, Arthur Drouaud, Noah Longton, Olivia Gordon iD, Kirolos Youssef, Jad Kfouri, Sarah Azari iD, Sean Tafuri, Briana Goddard, Michael J Whalen iD

Current Oncology · 2024

DOI: 10.3390/curroncol31050192 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Current Oncology, 2024. Verfasst von Ryan M Antar und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, School of Medicine, George Washington University, Washington, DC 20052, USA. Hauptthemen laut MEDLINE: Urinary Bladder Neoplasms, Lymph Node Excision, Neoadjuvant Therapy. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Muscle-invasive bladder cancer (MIBC) is a potentially fatal disease, especially in the setting of locally advanced or node-positive disease. Adverse outcomes have also primarily been associated with low-income status, as has been reported in other cancers. While the adoption of neoadjuvant cisplatin-based chemotherapy (NAC) followed by radical cystectomy (RC) and pelvic lymph node dissection (PLND) has improved outcomes, these standard-of-care treatments may be underutilized in lower-income patients. We sought to investigate the economic disparities in NAC and PLND receipt and survival outcomes in MIBC.

Methods

Utilizing the National Cancer Database, a retrospective cohort analysis of cT2-4N0-3M0 BCa patients with urothelial histology who underwent RC was conducted. The impact of income level on overall survival (OS) and the likelihood of receiving NAC and PLND was evaluated.

Results

A total of 25,823 patients were included. This study found that lower-income patients were less likely to receive NAC and adequate PLND (≥15 LNs). Moreover, lower-income patients exhibited worse OS (Median OS 55.9 months vs. 68.2 months, p < 0.001). Our findings also demonstrated that higher income, treatment at academic facilities, and recent years of diagnosis were associated with an increased likelihood of receiving standard-of-care modalities and improved survival.

Conclusions

Even after controlling for clinicodemographic variables, income independently influenced the receipt of standard MIBC treatments and survival. Our findings identify an opportunity to improve the quality of care for lower-income MIBC patients through concerted efforts to regionalize multi-modal urologic oncology care.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Urinary Bladder NeoplasmsLymph Node ExcisionNeoadjuvant TherapyHumansFemaleMaleAgedMiddle AgedRetrospective StudiesIncomeHealthcare DisparitiesPelvisCystectomyNeoplasm Invasiveness

Stichwörter der Autor:innen

MIBCbladder cancerincomesocioeconomic disparities

Autor:innen und Institutionen

  • Department of Urology, School of Medicine, George Washington University, Washington, DC 20052, USA.
  • School of Medicine, University of Illinois, Urbana-Champaign, Urbana, IL 60612, USA.
  • College of Medicine, Drexel University, Philadelphia, PA 19104, USA.

ORCID-Profile: Ryan M Antar, Vincent E Xu, Olivia Gordon, Sarah Azari, Michael J Whalen

Zitieren

APA

Antar, R. M., Xu, V. E., Adesanya, O., Drouaud, A., Longton, N., Gordon, O., Youssef, K., Kfouri, J., Azari, S., Tafuri, S., Goddard, B., & Whalen, M. J. (2024). Income Disparities in Survival and Receipt of Neoadjuvant Chemotherapy and Pelvic Lymph Node Dissection for Muscle-Invasive Bladder Cancer. Current Oncology. https://doi.org/10.3390/curroncol31050192

Vancouver

Antar RM, Xu VE, Adesanya O, Drouaud A, Longton N, Gordon O, et al. Income Disparities in Survival and Receipt of Neoadjuvant Chemotherapy and Pelvic Lymph Node Dissection for Muscle-Invasive Bladder Cancer. Current Oncology. 2024. doi:10.3390/curroncol31050192

BibTeX
@article{Antar2024,
  author = {Antar, Ryan M and Xu, Vincent E and Adesanya, Oluwafolajimi and Drouaud, Arthur and Longton, Noah and Gordon, Olivia and Youssef, Kirolos and Kfouri, Jad and Azari, Sarah and Tafuri, Sean and Goddard, Briana and Whalen, Michael J},
  title = {Income Disparities in Survival and Receipt of Neoadjuvant Chemotherapy and Pelvic Lymph Node Dissection for Muscle-Invasive Bladder Cancer},
  journal = {Current Oncology},
  year = {2024},
  doi = {10.3390/curroncol31050192}
}
Kostenlos starten →